Trial reportDrug design, development and therapy2025
Effect of Ephedrine versus Phenylephrine on Postoperative Delirium in Elderly Patients Undergoing Total Hip or Knee Arthroplasty: A Randomized Controlled Trial.
Trial report in Drug design, development and therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Postoperative delirium (POD) is a common complication in elderly patients. Since ephedrine and phenylephrine have different effects on cerebral perfusion and oxygenation, this randomized controlled trial aimed to compare the impact of these two drugs on the incidence of POD in elderly patients undergoing total hip or knee arthroplasty under general anesthesia. Patients and Methods: A total of 142 elderly patients, aged 65 to 80 years, who underwent elective surgery for total hip or knee arthroplasty were randomly assigned to either the ephedrine group (Group E) or the phenylephrine group (Group P). POD was evaluated using the 3-minute Diagnostic Confusion Assessment Method (3D-CAM). The primary outcome was the incidence of POD within three days after surgery, while secondary outcomes included the subtypes of delirium, intraoperative hemodynamic changes, intraoperative analgesic consumption, and the occurrence of intraoperative and postoperative adverse events. Results: Delirium occurred in 5 out of 65 cases (7.7%) in Group E and in 15 out of 67 cases (22.4%) in Group P (relative risk [RR], 0.344; 95% confidence interval [CI], 0.132 to 0.891; p = 0.019). Compared to Group P, Group E exhibited a significantly lower incidence of intraoperative bradycardia (RR, 0.241; 95% CI, 0.114 to 0.508; p < 0.001). However, Group E also demonstrated a significantly higher consumption of intraoperative opioids (median difference [MD], 23.0; 95% CI, 2.0 to 25.0 mg; p = 0.020). Notably, despite the higher intraoperative opioid consumption in Group E, there was no statistically significant difference in postoperative pain scores between the two groups (p > 0.05). Additionally, there were no statistically significant differences between the two groups in other indicators, including intraoperative hemodynamic changes and the incidence of postoperative nausea and vomiting (p > 0.05). Conclusion: In conclusion, among elderly patients undergoing hip or knee arthroplasty, the use of ephedrine to correct intraoperative hypotension was associated with a reduced incidence of POD within three days compared to phenylephrine. However, the absence of cerebral oxygen saturation monitoring and the limited follow-up period of only three days for POD assessment represent significant limitations. These factors should be carefully considered when interpreting our results.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.